Eight-Year Follow-Up of a Child with a GH/Prolactin-Secreting Adenoma: Efficacy of Pegvisomant Therapy

A 3.4-year-old girl was admitted to the Pediatric Department because of tall stature (116.0 cm, +5.1 SDS) and increased height velocity (16.3 cm/year, +6.1 SDS). Basal hormonal evaluation revealed elevated insulin-like growth factor I (IGF-I) levels (938 ng/ml, nv 40–190), prolactin (PRL) (98.0 ng/m...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Hormone research in paediatrics 2010-01, Vol.73 (1), p.74-79
Hauptverfasser:	Bergamaschi, S., Ronchi, C.L., Giavoli, C., Ferrante, E., Verrua, E., Ferrari, D.I., Lania, A., Rusconi, R., Spada, A., Beck-Peccoz, P.
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenoma - complications Adenoma - drug therapy Child, Preschool Female Follow-Up Studies Gigantism - drug therapy Gigantism - etiology Growth Hormone-Secreting Pituitary Adenoma - complications Growth Hormone-Secreting Pituitary Adenoma - drug therapy Hormone Antagonists - therapeutic use Human Growth Hormone - analogs & derivatives Human Growth Hormone - therapeutic use Humans Novel Insights from Clinical Practice Pituitary Neoplasms - complications Pituitary Neoplasms - drug therapy Prolactinoma - complications Prolactinoma - drug therapy Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!